Search

everythinglearnresearchcommunity

for

Search:↓

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Sex hormones affect liver fat and metabolic health differently in men and women.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Many young women in Pakistan are unaware of their PCOS symptoms.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.